vs
Idexx Laboratories（IDXX）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
RXO, Inc.的季度营收约是Idexx Laboratories的1.3倍（$1.5B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs -3.1%，领先25.9%），Idexx Laboratories同比增速更快（14.3% vs -11.9%），Idexx Laboratories自由现金流更多（$326.3M vs $-9.0M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
IDXX vs RXO — 直观对比
营收规模更大
RXO
是对方的1.3倍
$1.1B
营收增速更快
IDXX
高出26.2%
-11.9%
净利率更高
IDXX
高出25.9%
-3.1%
自由现金流更多
IDXX
多$335.3M
$-9.0M
两年增速更快
RXO
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.5B |
| 净利润 | $248.2M | $-46.0M |
| 毛利率 | 60.3% | — |
| 营业利润率 | 28.9% | -2.9% |
| 净利率 | 22.8% | -3.1% |
| 营收同比 | 14.3% | -11.9% |
| 净利润同比 | 14.8% | -84.0% |
| 每股收益（稀释后） | $3.09 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXRXO
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $998.4M | $1.4B | ||
| Q4 24 | $954.3M | $1.7B | ||
| Q3 24 | $975.5M | $1.0B | ||
| Q2 24 | $1.0B | $930.0M | ||
| Q1 24 | $964.1M | $913.0M |
净利润IDXXRXO
| Q4 25 | $248.2M | $-46.0M | ||
| Q3 25 | $274.6M | $-14.0M | ||
| Q2 25 | $294.0M | $-9.0M | ||
| Q1 25 | $242.7M | $-31.0M | ||
| Q4 24 | $216.1M | $-25.0M | ||
| Q3 24 | $232.8M | $-243.0M | ||
| Q2 24 | $203.3M | $-7.0M | ||
| Q1 24 | $235.6M | $-15.0M |
毛利率IDXXRXO
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 62.6% | — | ||
| Q1 25 | 62.4% | — | ||
| Q4 24 | 59.8% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 61.5% | — |
营业利润率IDXXRXO
| Q4 25 | 28.9% | -2.9% | ||
| Q3 25 | 32.1% | -0.5% | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 31.7% | -2.1% | ||
| Q4 24 | 27.4% | -1.4% | ||
| Q3 24 | 31.2% | -1.9% | ||
| Q2 24 | 26.3% | — | ||
| Q1 24 | 31.0% | -1.3% |
净利率IDXXRXO
| Q4 25 | 22.8% | -3.1% | ||
| Q3 25 | 24.8% | -1.0% | ||
| Q2 25 | 26.5% | -0.6% | ||
| Q1 25 | 24.3% | -2.2% | ||
| Q4 24 | 22.7% | -1.5% | ||
| Q3 24 | 23.9% | -23.4% | ||
| Q2 24 | 20.3% | -0.8% | ||
| Q1 24 | 24.4% | -1.6% |
每股收益（稀释后）IDXXRXO
| Q4 25 | $3.09 | $-0.28 | ||
| Q3 25 | $3.40 | $-0.08 | ||
| Q2 25 | $3.63 | $-0.05 | ||
| Q1 25 | $2.96 | $-0.18 | ||
| Q4 24 | $2.62 | $-0.17 | ||
| Q3 24 | $2.80 | $-1.81 | ||
| Q2 24 | $2.44 | $-0.06 | ||
| Q1 24 | $2.81 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $17.0M |
| 总债务越低越好 | $450.0M | $387.0M |
| 股东权益账面价值 | $1.6B | $1.5B |
| 总资产 | $3.4B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资IDXXRXO
| Q4 25 | $180.1M | $17.0M | ||
| Q3 25 | $208.2M | $25.0M | ||
| Q2 25 | $164.6M | $18.0M | ||
| Q1 25 | $164.0M | $16.0M | ||
| Q4 24 | $288.3M | $35.0M | ||
| Q3 24 | $308.6M | $55.0M | ||
| Q2 24 | $401.6M | $7.0M | ||
| Q1 24 | $397.4M | $7.0M |
总债务IDXXRXO
| Q4 25 | $450.0M | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | $617.8M | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $351.0M |
股东权益IDXXRXO
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.6B | $1.7B | ||
| Q2 24 | $1.6B | $579.0M | ||
| Q1 24 | $1.6B | $582.0M |
总资产IDXXRXO
| Q4 25 | $3.4B | $3.3B | ||
| Q3 25 | $3.4B | $3.2B | ||
| Q2 25 | $3.3B | $3.2B | ||
| Q1 25 | $3.2B | $3.3B | ||
| Q4 24 | $3.3B | $3.4B | ||
| Q3 24 | $3.4B | $3.4B | ||
| Q2 24 | $3.4B | $1.8B | ||
| Q1 24 | $3.4B | $1.8B |
负债/权益比IDXXRXO
| Q4 25 | 0.28× | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | 0.39× | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $-9.0M |
| 自由现金流率自由现金流/营收 | 29.9% | -0.6% |
| 资本支出强度资本支出/营收 | 2.7% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | $-8.0M |
8季度趋势，按日历期对齐
经营现金流IDXXRXO
| Q4 25 | $355.8M | $7.0M | ||
| Q3 25 | $402.3M | $23.0M | ||
| Q2 25 | $185.7M | $23.0M | ||
| Q1 25 | $238.0M | $-2.0M | ||
| Q4 24 | $262.0M | $-7.0M | ||
| Q3 24 | $220.1M | $-7.0M | ||
| Q2 24 | $248.3M | $-5.0M | ||
| Q1 24 | $198.6M | $7.0M |
自由现金流IDXXRXO
| Q4 25 | $326.3M | $-9.0M | ||
| Q3 25 | $371.2M | $9.0M | ||
| Q2 25 | $151.6M | $9.0M | ||
| Q1 25 | $207.9M | $-17.0M | ||
| Q4 24 | $232.8M | $-19.0M | ||
| Q3 24 | $192.0M | $-18.0M | ||
| Q2 24 | $215.0M | $-16.0M | ||
| Q1 24 | $168.3M | $-4.0M |
自由现金流率IDXXRXO
| Q4 25 | 29.9% | -0.6% | ||
| Q3 25 | 33.6% | 0.6% | ||
| Q2 25 | 13.7% | 0.6% | ||
| Q1 25 | 20.8% | -1.2% | ||
| Q4 24 | 24.4% | -1.1% | ||
| Q3 24 | 19.7% | -1.7% | ||
| Q2 24 | 21.4% | -1.7% | ||
| Q1 24 | 17.5% | -0.4% |
资本支出强度IDXXRXO
| Q4 25 | 2.7% | 1.1% | ||
| Q3 25 | 2.8% | 1.0% | ||
| Q2 25 | 3.1% | 1.0% | ||
| Q1 25 | 3.0% | 1.0% | ||
| Q4 24 | 3.1% | 0.7% | ||
| Q3 24 | 2.9% | 1.1% | ||
| Q2 24 | 3.3% | 1.2% | ||
| Q1 24 | 3.1% | 1.2% |
现金转化率IDXXRXO
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.21× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
